Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

A preliminary study of dopamine-mediated prolactin inhibition in generalised social phobia.

Condren RM, Sharifi N, Thakore JH.

Psychiatry Res. 2002 Aug 5;111(1):87-92.

PMID:
12140123
2.
3.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
4.

Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia.

Tancer ME, Mailman RB, Stein MB, Mason GA, Carson SW, Golden RN.

Anxiety. 1994-1995;1(5):216-23.

PMID:
9160577
5.

A preliminary study of baclofen-induced growth hormone release in generalised social phobia.

Condren RM, Lucey JV, Thakore JH.

Hum Psychopharmacol. 2003 Mar;18(2):125-30.

PMID:
12590406
6.

Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humans.

Gerra G, Zaimovic A, Moi G, Giusti F, Gardini S, Delsignore R, Laviola G, Macchia T, Brambilla F.

Behav Brain Res. 2002 Aug 21;134(1-2):403-10.

PMID:
12191827
7.

The prolactin response to sulpiride in major depression: the role of the D2 receptor in depression.

Verbeeck WJ, Berk M, Paiker J, Jersky B.

Eur Neuropsychopharmacol. 2001 Jun;11(3):215-20.

PMID:
11418281
8.

Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects.

Hollander E, Kwon J, Weiller F, Cohen L, Stein DJ, DeCaria C, Liebowitz M, Simeon D.

Psychiatry Res. 1998 Jul 13;79(3):213-7.

PMID:
9704868
10.

Lymphocyte beta-adrenoceptors in social phobia.

Stein MB, Huzel LL, Delaney SM.

Biol Psychiatry. 1993 Jul 1-15;34(1-2):45-50.

PMID:
8396992
11.

Growth hormone and prolactin response to apomorphine in bipolar and unipolar depression.

McPherson H, Walsh A, Silverstone T.

J Affect Disord. 2003 Sep;76(1-3):121-5.

PMID:
12943941
12.

Citalopram challenge in social anxiety disorder.

Shlik J, Maron E, Tru I, Aluoja A, Vasar V.

Int J Neuropsychopharmacol. 2004 Jun;7(2):177-82. Epub 2004 Jan 23.

PMID:
14741063
13.

Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone.

Cassidy EM, Tomkins E, Sharifi N, Dinan T, Hardiman O, O'Keane V.

Pain. 2003 Feb;101(3):283-90.

PMID:
12583871
14.

Magnetic resonance imaging in social phobia.

Potts NL, Davidson JR, Krishnan KR, Doraiswamy PM.

Psychiatry Res. 1994 Apr;52(1):35-42.

PMID:
8047620
15.

Dopamine function in obsessive compulsive disorder: cortisol response to acute apomorphine stimulation.

Brambilla F, Perna G, Bussi R, Bellodi L.

Psychoneuroendocrinology. 2000 Apr;25(3):301-10.

PMID:
10737700
16.

Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings.

Schneier FR, Martinez D, Abi-Dargham A, Zea-Ponce Y, Simpson HB, Liebowitz MR, Laruelle M.

Depress Anxiety. 2008;25(1):1-7.

PMID:
17252580
17.

Serotonergic and dopaminergic neuroendocrine responses of male depressive patients before and after a therapeutic ECT course.

Markianos M, Hatzimanolis J, Lykouras L.

Eur Arch Psychiatry Clin Neurosci. 2002 Aug;252(4):172-6.

PMID:
12242578
18.

Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests.

Duval F, Mokrani MC, Monreal J, Bailey P, Valdebenito M, Crocq MA, Macher JP.

Psychoneuroendocrinology. 2003 Jul;28(5):627-42.

PMID:
12727131
19.

Social phobia in coeliac disease.

Addolorato G, Mirijello A, D'Angelo C, Leggio L, Ferrulli A, Vonghia L, Cardone S, Leso V, Miceli A, Gasbarrini G.

Scand J Gastroenterol. 2008;43(4):410-5. doi: 10.1080/00365520701768802.

PMID:
18365905
20.

Regulation of central dopamine-2 receptor sensitivity by a proportional control thermostat in humans.

Schwartz PJ, Erk SD.

Psychiatry Res. 2004 Jun 30;127(1-2):19-26.

PMID:
15261701
Items per page

Supplemental Content

Write to the Help Desk